Jasper Westerink took up the post in December 2016 with the aim of accelerating development of Philips’ health technology portfolio.
“I’m very proud to be appointed as CEO Philips Africa. My priorities, in a region facing ongoing challenges, are to continue to identify growth opportunities and boost Philips’ commitment to develop sustainable solutions for our African customers and consumers,” said Westerink.
“Building-up and maintaining strong relations with government and business groups is essential. Philips has a long history and presence in Africa of over a hundred years. Through our emphasis on improving people’s lives and our strong focus on providing relevant and sustainable solutions, we are convinced that we are well-positioned to further grow our presence across the African continent,” continued Westerink.
Westerink has been with Philips since 2001 and brings with him a wealth of experience and international business expertise having worked in key leadership positions across Europe, Africa and Asia Pacific. He spent a couple of years as the head of the Consumer Lifestyle portfolio for Philips in South Africa before relocating to Indonesia where he was the Managing Director of Personal Health, Indonesia. Under his leadership Indonesia has become one of the fastest growing countries for Philips in the APAC market.
“Society’s key health challenges – ageing population, increase in chronic illnesses, rising health expenses has lead us to imagine new solutions. The challenge is not simply to develop new products; we also need new services and new business models. Philips is a world leader in health solutions, as much for consumers as for professionals and medical establishments,” said Westerink.
“In Africa, Philips innovations have been part of everyday life for many generations. Our well-trusted name combined with the strength of the group’s local research and development capabilities are key resources to help transform our healthcare system, moving towards greater quality and efficiency with predictive, preventive and personalised medicine for tomorrow,” concluded Westerink.
Westerink holds a Master Degree in Social Sciences with a specialisation in Management and Marketing from the University of Tilburg in the Netherlands. He has additional qualifications from Harvard Business School (Digital & Social Strategy), the University of Chicago School of Business (Strategic Sales Management) and Northwestern University – Kellogg School of Management (Strategic consumer marketing).